YDES

Conviction 53HealthcareScan · Fri, Oct 9, 2026

YD Bio Ltd (YDES) closed at $6.73 (+16.23%) on Oct 9, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 61, RS Rating 99, -66.1% from its 52-week high, -43.3% year to date. Sector: Healthcare.

YDES$6.73+16.23%

ResistanceSupportVol 14

Vol MA14 546.24K

Jul 14Jul 30Aug 18Sep 3Sep 23Oct 9

YD Bio Ltdwww.ydesgroup.com ↗

Price6.73

Change+16.23%

Gap+0.86%

Rel volume0.16×

Avg volume559.36K

Avg $ vol2.74M

SMA 205.34

SMA 504.24

SMA 2005.99

Price vs 50+60.55%

Price vs 200+13.68%

MA stackmixed

50/200 cross—

Supertrendup · 4.59

RSI (14)61

MACD hist0.01

MACD cross—

Stoch %K / %D73 / 62

ADX (14)31

+DI / −DI26 / 16

RSI divergence—

MACD divergence—

ATR %15.23%

ADR %19.89%

52w high20.09

52w low1.90

From 52w high-66.10%

Above 52w low+258.42%

New 52w highNo

SqueezeOff

Bollinger width137.38%

%B0.70

Donchian pos73.04%

Donchian high8.43

Donchian low2.42

AVWAP (52w high)5.32

vs AVWAP high+28.12%

AVWAP (52w low)3.86

vs AVWAP low+76.40%

OBV trendUp

Chaikin MF (20)0.21

Today vs 20d0.16×

Avg vol (14d)538.3K

Avg vol (20d)559.36K

Avg $ vol (20d)2.74M

Market cap482.07M

RS Rating99 / 99

RS 3m (vs SPY)+212.83%

RS 6m (vs SPY)-5.79%

RS line new highNo

Trend template4/8

Technical rank91.8

1 week-16.03%

1 month+74.62%

3 months+216.74%

6 months+8.79%

1 year-60.08%

YTD-43.25%

P/E—

P/B-168.81

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current5.88

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value476.07M

Revenue—

Net income—

Gross profit—

Free cash flow—

Industry—

ExchangeNasdaq

Shares out70.79M

Employees15

ListedFri, Aug 29, 2025

Free float13.84M

Float %19.6%

Short interest13.29K

Days to cover0.1d

Short volume35.5%

Squeeze score1 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction53 / 100

Pattern quality—

Tech rank91.8 / 100

Group rank14 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.72

Support2.76

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in YDES

All disclosures →

No recent disclosed trades by Congress in YDES. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in YDES

No recent insider (Form 4) filings in YDES. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in YDES · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.